Pharvaris N.V.
PHVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $30 | $30 | $31 | $33 |
| G&A Expenses | $10 | $11 | $11 | $0 |
| SG&A Expenses | $10 | $11 | $11 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$84 | $0 |
| Operating Expenses | $40 | $40 | -$42 | $48 |
| Operating Income | -$40 | -$40 | $42 | -$48 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$5 | -$88 | $12 |
| Pre-Tax Income | -$37 | -$45 | -$46 | -$36 |
| Tax Expense | -$0 | $0 | $0 | $1 |
| Net Income | -$37 | -$45 | -$46 | -$37 |
| % Margin | – | – | – | – |
| EPS | -0.6 | -0.83 | -0.85 | -0.64 |
| % Growth | 27.7% | 2.4% | -32.8% | – |
| EPS Diluted | -0.6 | -0.83 | -0.85 | -0.64 |
| Weighted Avg Shares Out | 62 | 55 | 55 | 54 |
| Weighted Avg Shares Out Dil | 62 | 55 | 55 | 54 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$37 | -$40 | -$42 | -$36 |
| % Margin | – | – | – | – |